Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 57 (RNA5SP57)

Target
RNA5SP57
Molecular classification
Pseudogene, non-coding RNA, processed pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 57 is a processed pseudogene derived from the 5S rRNA gene. Processed pseudogenes arise via retrotransposition of mRNA transcripts and generally lack protein-coding potential or strong regulatory functions. However, some pseudogenes can be transcribed into non-coding RNAs, possibly serving regulatory roles through antisense interactions or generation of small RNAs, influencing gene expression networks. No clinical, pharmacological, or biomarker relevance has been associated with RNA5SP57 to date[2][4][6]. The presence of multiple similar names (RN5S57, RN5S58, etc.) suggests gene duplication or sequencing annotation artifacts rather than biological distinction. None of these are considered actionable therapeutic targets, and their scientific relevance is limited to genomic characterization and theoretical gene regulation.

Other names
RN5S57RN5S58RNA5SP58RNA, 5S ribosomal 57RNA, 5S ribosomal 58RNA, 5S ribosomal pseudogene 58RNA5SP57
02

Mechanism of action

Not applicable

03

Biological functions

Potential regulatory role at the RNA level (e.g., production of antisense transcripts, source of RNA fragments)no direct function as a protein-coding gene or receptor
04

Disease associations

None clearly established; pseudogenes can participate in gene regulation and may be involved in some diseases, but no specific disease association for RNA5SP57 is described
05

Safety considerations

Not applicable
06

Interacting drugs

None known; not targeted by any therapeutic agents
07

Biomarkers

Not used as a biomarker for patient selection or monitoring

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 57 (RNA5SP57).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 57 (RNA5SP57).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call